Axxcess Wealth Management LLC Cuts Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Axxcess Wealth Management LLC decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.1% in the fourth quarter, HoldingsChannel reports. The fund owned 9,482 shares of the medical equipment provider’s stock after selling 611 shares during the quarter. Axxcess Wealth Management LLC’s holdings in Intuitive Surgical were worth $4,949,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. Cassady Schiller Wealth Management LLC boosted its position in shares of Intuitive Surgical by 1.6% in the 4th quarter. Cassady Schiller Wealth Management LLC now owns 1,539 shares of the medical equipment provider’s stock worth $803,000 after purchasing an additional 24 shares in the last quarter. Signaturefd LLC raised its stake in Intuitive Surgical by 4.2% in the fourth quarter. Signaturefd LLC now owns 7,808 shares of the medical equipment provider’s stock valued at $4,075,000 after buying an additional 315 shares during the last quarter. Parallel Advisors LLC boosted its holdings in Intuitive Surgical by 10.8% in the fourth quarter. Parallel Advisors LLC now owns 40,283 shares of the medical equipment provider’s stock worth $21,026,000 after acquiring an additional 3,914 shares in the last quarter. Cibc World Markets Corp increased its holdings in shares of Intuitive Surgical by 14.5% during the fourth quarter. Cibc World Markets Corp now owns 64,026 shares of the medical equipment provider’s stock valued at $33,419,000 after acquiring an additional 8,100 shares in the last quarter. Finally, SouthState Corp raised its position in shares of Intuitive Surgical by 5.5% in the 4th quarter. SouthState Corp now owns 39,315 shares of the medical equipment provider’s stock valued at $20,521,000 after purchasing an additional 2,035 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now owns 5,758 shares of the company’s stock, valued at approximately $2,793,033.06. The trade was a 60.72 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 in the last quarter. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Down 1.0 %

NASDAQ ISRG opened at $483.95 on Wednesday. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The stock has a 50-day moving average of $565.43 and a 200 day moving average of $531.90. The stock has a market capitalization of $172.37 billion, a price-to-earnings ratio of 75.50, a PEG ratio of 5.85 and a beta of 1.43.

Analysts Set New Price Targets

ISRG has been the topic of several research analyst reports. UBS Group boosted their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Wells Fargo & Company boosted their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Leerink Partners raised their target price on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Jefferies Financial Group boosted their price target on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Finally, Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.